Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs T-Rex 2X Long MSTR Daily Target ETF (MSTU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs T-Rex 2X Long MSTR Daily Target ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while T-Rex 2X Long MSTR Daily Target ETF trades at $32.29 (market cap $790.58M). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 39.3× T-Rex 2X Long MSTR Daily Target ETF's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while T-Rex 2X Long MSTR Daily Target ETF pays none. Which is the better fit depends on your goals.
| GEHC | MSTU | |
|---|---|---|
Market Cap | $31.07B | $790.58M |
Volume | 3,443,020 | 1,852,380 |
Sector | Health | Leveraged / Inverse |
52-Week High | $88.16 | $389.00 |
52-Week Low | $59.48 | $14.60 |
Enterprise Value | $39.53B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 19 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
MSTU trades at $38.54, down 0.57% with a bearish technical signal. The stock faces resistance at $40-$45 while finding support at $37-$33 levels. Recent corporate actions include a 10:1 reverse stock split effective August 24, 2026, and a $0.29 dividend declaration. Trading activity remains elevated as investors seek leveraged exposure to the underlying company amid market volatility.
The outlook remains cautious with technical indicators showing bearish momentum and limited fundamental data available. Key risks include the leveraged ETF structure's daily compounding effects and dependence on underlying stock performance. Investors should monitor for updated financial disclosures and analyst coverage to assess the fund's positioning and valuation metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →
